CI Investments Inc
MRVI icon

CI Investments Inc’s Maravai LifeSciences MRVI Stock Holding History

CI Investments Inc’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-6
Closed – – 1337
2023
Q1 		$0 Hold
6
– – ﹤0.01% 1253
2022
Q4 		$0 Buy
6
+1
+20% +$16 ﹤0.01% 1303
2022
Q3 		$0 Hold
5
– – ﹤0.01% 1313
2022
Q2 		$0 Hold
5
– – ﹤0.01% 1353
2022
Q1 		$0 Hold
5
– – ﹤0.01% 1386
2021
Q4 		$0 Hold
5
– – ﹤0.01% 1378
2021
Q3 		$0 Buy
+5
New +$244 ﹤0.01% 1337
2021
Q2 		– Sell
-20,385
Closed -$727K – 1066
2021
Q1 		$727K Buy
20,385
+6,248
+44% +$207K ﹤0.01% 451
2020
Q4 		$397K Buy
+14,137
New +$394K ﹤0.01% 568

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

CI Investments Inc's MRVI Position: Q2 2023 in Review

CI Investments Inc sold out of Maravai LifeSciences (MRVI) in Q2 2023, closing a stake of 6 shares.

CI Investments Inc first reported a position in MRVI in Q4 2020 and held it in 9 quarters. The position peaked at $727K in Q1 2021. 221 funds tracked by Wall St. Rank hold MRVI as of Q2 2023.

  • CI Investments Inc reported no remaining Maravai LifeSciences position as of Q2 2023 after selling out during the quarter.
  • CI Investments Inc sold 6 Maravai LifeSciences shares in Q2 2023.
  • CI Investments Inc first reported a position in Maravai LifeSciences in Q4 2020 and held it in 9 quarters.
  • CI Investments Inc's Maravai LifeSciences position peaked at $727K in Q1 2021.
  • 221 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2023.

Based on CI Investments Inc's 13F filing for Q2 2023, filed 11 Aug 2023.